Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

30.03
Delayed Data
As of Feb 05
 -0.44 / -1.44%
Today’s Change
29.50
Today|||52-Week Range
36.69
-11.55%
Year-to-Date
AstraZeneca Tops Q4 Earnings, Falls on Bleak 2016 Outlook
Feb 05 / Zacks.com
Novartis (NVS) Lags Q4 Earnings & Revenues, Alcon Down
Jan 28 / Zacks.com
Frontrunning: February 5
Feb 05 / Investing Channel
Eli Lilly Tops on 4Q Earnings, Revenues, Maintains View
Jan 28 / Zacks.com
AstraZeneca (AZN) Earnings Report: Q4 2015 Conference Call Transcript
Feb 04 / TheStreet.com
Johnson & Johnson's Newest Billion-Dollar Blockbuster
Jan 28 / MotleyFool.com
Here’s Why AstraZeneca (AZN) Stock is Dropping Today
Feb 04 / TheStreet.com
Will AbbVie (ABBV) Keep the Earnings Streak Alive in Q4?
Jan 27 / Zacks.com
What Makes Abbott Laboratories (ABT) a Strong Sell?
Feb 04 / Zacks.com
Will Currency Volatility Keep Hurting Abbott's (ABT) Earnings?
Jan 27 / Zacks.com
AstraZeneca (AZN) Flagged As Today's Pre-Market Laggard
Feb 04 / TheStreet.com
Forget Inovio Pharmaceuticals, Inc.: These 2 Stocks Are Better Buys
Jan 26 / MotleyFool.com
European Stocks Rise as Oil Prices Recover
Feb 04 / TheStreet.com
Will Weak Pricing Impact McKesson's (MCK) Earnings in Q3?
Jan 26 / Zacks.com
Merck Tops on Q4 Earnings, Revenue Outlook Falls Short
Feb 03 / Zacks.com
Will Amgen (AMGN) Continue with the Earnings Streak in Q4?
Jan 26 / Zacks.com
3 Drugs Stocks Nudging The Industry Higher
Feb 01 / TheStreet.com
Will Lilly (LLY) Keep the Earnings Streak Alive in Q4?
Jan 26 / Zacks.com
3 Feverishly Bad Flu Myths That Should Be Put to Rest
Jan 31 / MotleyFool.com
Why Shares of Relypsa Are Climbing Today
Jan 26 / MotleyFool.com
AstraZeneca's Lynparza Gets Breakthrough Therapy Status
Jan 29 / Zacks.com
J&J's Q4 Results Mixed with Earnings Beat, Revenue Miss
Jan 26 / Zacks.com
AbbVie Posts In-Line Earnings, Maintains 2016 Outlook
Jan 29 / Zacks.com
The 1 Biotech Stock I Want to Own in 2016
Jan 26 / MotleyFool.com
Can Gilead (GILD) Keep the Earnings Streak Alive in Q4?
Jan 29 / Zacks.com
Will Biogen (BIIB) Beat 4Q Earnings on MS Franchise Sales?
Jan 25 / Zacks.com
Weakness Seen in Abbott Laboratories (ABT): Stock Tumbles 9.3%
Jan 29 / Zacks.com
Will Higher Expenses Hurt Vertex's (VRTX) 4Q Earnings?
Jan 25 / Zacks.com
Will 2016 Be Valeant Pharmaceuticals' Best Year Yet?
Jan 29 / MotleyFool.com
Novartis (NVS) to Report Q4 Earnings: Will It Disappoint?
Jan 25 / Zacks.com
McKesson Q3 Earnings Top on Low Tax Rate, Revenues Miss
Jan 28 / Zacks.com
Will Currency and Generics Hit J&J's (JNJ) Q4 Earnings?
Jan 25 / Zacks.com